Vioxx's Long Shadow: Supreme Court Skeptical Of Merck's Argument On Timing Of Securities Suits
This article was originally published in The Pink Sheet Daily
Executive Summary
Case could determine how much evidence is necessary for investors to bring a securities fraud suit to start the clock running on the statute of limitations.